Pyxis Oncology Inc (PYXS)
3.62
-0.10
(-2.69%)
USD |
NASDAQ |
Sep 27, 16:00
3.615
0.00 (0.00%)
After-Hours: 20:00
Pyxis Oncology Cash from Financing (Quarterly): 0.11M for June 30, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.11M |
| March 31, 2024 | 57.51M |
| December 31, 2023 | -0.025M |
| September 30, 2023 | -0.171M |
| June 30, 2023 | 6.125M |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2022 | 0.006M |
| June 30, 2022 | 0.001M |
| March 31, 2022 | 0.176M |
| December 31, 2021 | 154.90M |
| September 30, 2021 | -1.708M |
| June 30, 2021 | -0.682M |
| March 31, 2021 | 151.53M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.708M
Minimum
Sep 2021
154.90M
Maximum
Dec 2021
26.27M
Average
0.0035M
Median
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.492M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 12.99M |
| Theriva Biologics Inc | 1.773M |
| Oragenics Inc | 0.8212M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -3.007M |
| Cash from Investing (Quarterly) | 0.004M |
| Free Cash Flow | -56.85M |
| Free Cash Flow Per Share (Quarterly) | -0.0497 |
| Free Cash Flow Yield | -31.79% |